Second, the SEER‐Medicare database did not contain information on some behavior characteristics (e.g., smoking) or results of lab tests, such as driver mutation status including JAK2‐V617F mutation and lipid profile to identify patients with dyslipidemia, so we could not incorporate these data into the analysis. The gene discussed is JAK2; the disease is metabolic syndrome.